Sanquin is a not-for-profit organization that provides the blood supply. They are also involved in making reagents, conducting research and providing education. They develop diagnostic tests that prevent the waste of expensive medicines or unnecessary treatments.

MOLOGEN AG engages in the research and clinical development of drugs in the fields of oncology and infectious diseases. Its products include lefitolimod and its follow-up molecules EnanDIM, and cell-based therapeutic vaccine MGN1601. The company was founded by Matthias P. Schlichting and Burghardt Wittig on January 14, 1998 and is headquartered in Berlin, Germany.

CAVΛDIS™ is a Dutch biomedical company active in the field of cardiovascular risk assessment. They develop prognostic tests to identify patients at risk of cardiovascular and disease. The company identified several novel biomarkers predictive for cardiovascular events. It is their goal is to develop clinically meaningful risk stratification tools that will help personalize treatment and achieve better patient outcomes.

Part of Sciona, Inc., Genostic Pharma Ltd. is a company headquartered in Cambridge, UK, specializing in commercial physical and biological research. It was acquired by Sciona, Inc. on February 22, 2002.

OSSIANIX is a privately held biotherapeutics company that develops single domain antibodies based on the highly versatile VNAR structure from shark. Due to remarkable biological and biophysical properties, the VNAR platform can rapidly deliver unique, exquisitely high-affinity products to multiple target classes and overcomes most disadvantages of conventional monoclonal antibody therapy. The platform is also ideal for generating bispecific and trispecific products that can be engineered with ease to develop products with differentiated features in clinically meaningful conditions and also allow targeting to both the blood brain barrier and GI tract for CNS and oral applications.

Academisch Ziekenhuis Maastricht operates as medical research centre. The company is headquartered in Maastricht, the Netherlands.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Dalian Kerong Biotechnology Co., Ltd., established on 2011-12-05, The scope of business includes the development of biotechnology,technical consulting,technology transfer;Domestic general trade,goods,Technology Import and Export(law,Except for items prohibited by administrative regulations;law,Projects restricted by administrative regulations can only be operated after obtaining industry permits).****(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Axis Associate Consultants Ltd. (doing business as Aspion) is a private company headquartered in the United Kingdom. The firm provides temporary, contract & permanent staffing solutions.

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

Oxford has an introduction of an e-commerce business and also the launch and development of brand licensing programs for both the belted and shield trademarks. Oxford is a subsidiary company, wholly owned by the university of oxford. They are responsible for registration, protection, and management of the university's brand, and they use this to license the use of the brand, in a wide variety of commercial categories, globally.

Suzhou Yida Biotechnology Co., Ltd., established on 2014-11-03, The scope of business includes engaging in biological research,the medical,Instruments and accessories for beauty and health care,Consumables Research,to develop,production and sales,And provide related technology transfer,technical consulting,Technical Services;Engaged in the import and export business of the above products and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Pharmaceutical special equipment manufacturing;Pharmaceutical special equipment sales;Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of Drug Testing Instruments;Drug testing equipment sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Cyto Pulse Sciences, Inc. is a biomedical device and treatment development company creating innovative technology to produce and deliver new therapeutics for cancer (immunotherapy), infectious diseases (prophylaxis therapy), and genetic defects (gene therapy). Cyto Pulse technology is used in a wide range of fields including monoclonal antibody discovery, polynucleotide vaccine production, and delivery of polynucleotide (DNA/RNA) vaccines.

Taizhou Medical City Boao Bangke Biotechnology Co., Ltd., established on 2010-07-22, The scope of business includes research and development of tissue chip technology and other related biomedical technologies,Scientific research and clinical testing reagents(Removal of drugs and hazardous chemicals)research and development,laboratory reagent(Removal of drugs and hazardous chemicals),Equipment sales and related technical consultation,Technical service and technology transfer;Bioinformatics software development,make and sell,Goods and technology import and export business;Medical Device Sales;Health food research and development and sales;Catering Services;food sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Cosmetics Retail;Cosmetics Wholesale;General merchandise sales;Daily necessities sales;Daily necessities wholesale;Sales of hygiene products and single-use medical products;Health Care Services(non-medical);Traditional Chinese Medicine Health Care Services(non-medical);glasses sales(Contact lenses not included)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is ARIKAYCE® (amikacin liposome inhalation suspension), which is approved in the United States for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. MAC lung disease is a rare and often chronic infection that can cause irreversible lung damage and can be fatal. Insmed's earlier-stage clinical pipeline includes INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases, and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for rare pulmonary disorders, including pulmonary arterial hypertension.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Xinfeng Biotechnology (Shanghai) Co., Ltd., established on 2001-09-17, Business scope includes general items:Novel drug delivery system,Development of new pharmaceutical preparations,Research and development of new biological drugs,Chiral intermediate,racemic intermediate,Halogen Substituent Aromatic Compounds,asymmetric synthetic agent,Research and development of polyethylene glycol derivatives(human stem cells,Development and application of genetic diagnosis and treatment technology),own technology transfer,Environmental information consultation.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Nanjing Shihejiyin Technology, Inc. provides cancer treatment services. The company was founded by Yang Shao in 2008 and is headquartered in Nanjing, China.

Nanjing Shihe Medical Equipment Co., Ltd., established on 2015-11-27, Business scope includes medical device production(Operate according to the scope listed in the license);Class I medical device sales,Serve;Class III medical device sales(Operate according to the scope listed in the license);biological reagent(Does not contain hazardous chemicals)research and development,Production,Sales,technology transfer,Technical Services;Enterprise Marketing Planning;Business Management Consulting;account Serive;vocational skills training;Research and development of biotechnology,Technical Services,technical consulting,technology transfer;Chemical raw materials and products(In addition to pesticides,Hazardous Chemicals),Computer hardware and software and auxiliary equipment(In addition to special products for computer information system security),knitted goods,Cleaning Products,bed linings,daily necessities(In addition to electric tricycle),Communication equipment,Sales of Stationery;Industrial Investment;Realtor;Self-operated and agent import and export business of various commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Haoyuan Biotechnology Co. Ltd. Researches and develops biological products for HIV detection. Its products include ChiTas BSS1200 System, HAMILTON System, EZbead System-32 and ABI 7500 Real-Time PCR Systems. The company was founded by Huang Daopei in 1997 and is headquartered in Shanghai, China.